Inventor
ALBÆK NANNA
DK15 patents
⚠️ This page may combine multiple inventors who share the name “ALBÆK NANNA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ROCHE INNOVATION CT COPENHAGEN AS
12 patentsUS9879265B2Jan 30, 2018
Oligonucleotide conjugates
ROCHE INNOVATION CT COPENHAGEN AS17 citations92
US10077443B2Sep 18, 2018
Oligonucleotide conjugates
ROCHE INNOVATION CT COPENHAGEN AS10 citations83
US11267843B2Mar 8, 2022
Stereodefining L-monomers
ROCHE INNOVATION CT COPENHAGEN AS2 citations71
US10443058B2Oct 15, 2019
Antisense oligomers targeting PCSK9
ROCHE INNOVATION CT COPENHAGEN AS1 citations71
US10385342B2Aug 20, 2019
Methods of treatment using antisense oligomers and conjugates targeting PCSK9
ROCHE INNOVATION CT COPENHAGEN AS1 citations71
US10370668B2Aug 6, 2019
Manufacture of antisense oligomers and conjugates targeting PCSK9
ROCHE INNOVATION CT COPENHAGEN AS1 citations71
US12421516B2Sep 23, 2025
Antisense oligomers targeting PCSK9
ROCHE INNOVATION CT COPENHAGEN AS0 citations61
US11739332B2Aug 29, 2023
Antisense oligomers targeting PCSK9
ROCHE INNOVATION CT COPENHAGEN AS0 citations61
US11155816B2Oct 26, 2021
Oligonucleotide conjugates
ROCHE INNOVATION CT COPENHAGEN AS0 citations61
US11091764B2Aug 17, 2021
Antisense oligomers targeting PCSK9
ROCHE INNOVATION CT COPENHAGEN AS0 citations61
US10815481B2Oct 27, 2020
Chiral library screen
ROCHE INNOVATION CT COPENHAGEN AS0 citations49
US12421268B2Sep 23, 2025
Process for preparing nucleotide P(V) monomers
ROCHE INNOVATION CT COPENHAGEN AS0 citations41
HOFFMANN LA ROCHE
3 patentsUS10358643B2Jul 23, 2019
Poly oligomer compound with biocleavable conjugates
HOFFMANN LA ROCHE7 citations83
US11505569B2Nov 22, 2022
GalNAc phosphoramidites, nucleic acid conjugates thereof and their use
HOFFMANN LA ROCHE2 citations72
US11248019B2Feb 15, 2022
Trityl-mono-GalNAc compounds and their use
HOFFMANN LA ROCHE0 citations51